Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NIC | FRSH |
|---|---|---|
| Price | $164.62 | $13.22 |
| Change today | ▼ 1.11% | ▲ 3.44% |
| Market cap | $3.45B | $3.45B |
| Return, 3 months | -0.1% | +27.4% |
| Return, year to date | +36.6% | +7.9% |
| Return, 1 year | +22.8% | +16.9% |
| P/E (TTM) | 18.5 | 21.0 |
| P/B | 1.5 | 3.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.80% | – |
| Revenue growth (YoY, latest qtr) | +85.7% | – |
| Net profit growth (YoY) | +57.9% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 29.7% | – |
| Return on equity | 8.9% | – |
| Analyst target vs. price | +17.2% | +21.0% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 42 | 59 |
| 30-day volatility | 16.2% | 43.3% |
| Max drawdown, 1 year | -17.9% | -48.8% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
